Galapagos NV - ADR

NASDAQ:GLPG   4:00:00 PM EDT
32.95
+0.24 (+0.73%)
4:00:05 PM EDT: $32.95 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)2.17B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$71.45 Million
Adjusted EPS-$0.22
See more estimates
10-Day MA$33.29
50-Day MA$36.44
200-Day MA$37.88
See more pivots

Galapagos NV - ADR Stock, NASDAQ:GLPG

Industriepark Mechelen Noord, Generaal de Wittelaan L11 A3, Mechelen, Brussels Region 2800
Belgium
Phone: +32.1.534.29.00
Number of Employees: 1338

Description

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.